All Sustainability articles
-
-
-
Interview
Bengt Mattson reflects on sustainability
Bengt Mattson is Policy Manager at LiF, the trade association for the research-based pharmaceutical industry in Sweden. He is also the Co-chair of the three European pharmaceutical trade associations’ (AESGP, EFPIA and MfE) Task Force on pharmaceutical and environmental impacts. In this interview with Alan Booth, he reflects on sustainability in the regulatory environment.
-
-
-
Podcasts
RegRapPod − In Conversation with Bengt Mattson
BONUS EPISODE: In Conversation talking sustainability with Bengt Mattson
-
Journal
Does sole dependence on reliance models contribute to a sustainable healthcare ecosystem?
Governments should strive for a sustainable and global regulatory framework adept to deal with a healthcare crisis and similar issues that may arise in the future. This article looks at regulatory frameworks in international regions through AstraZeneca’s experience with the VaxzevriaTM vaccine.
-
Editorial
The future of pharmaceuticals is green
The healthcare sector is not immune from societal concerns about the environment and will have to go green over the next few years
-
Journal
Planning for the future: sustainable medical devices
Pharmaceutical and medical device companies are increasingly looking at new ways to incorporate sustainability into their strategies in a bid to help the environment. While existing medical device standards do not address sustainability explicitly, ISO working groups and others are now considering sustainability as an important component of medical device development. The heavily regulated world of medical devices will likely see sustainability standards emerging in the next decade.
-
Journal
Electronic leaflet pilot in Belgium and Luxembourg hospitals
The e-PIL Pilot was set-up in Belgium and Luxembourg with the objective to demonstrate the equivalence between the paper patient information leaflet and the electronic patient information leaflet in providing information on the safe and effective use of medicines in hospital setting. The first results of the Pilot are promising ...